Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2020 | Overview of HSCT and GvHD at EBMT

Regis Peffault de Latour • 3 Sep 2020
EBMT 2020
General

Régis Peffault de Latour, MD, PhD, Saint-Louis Hospital, Paris, France, provides an overview of a talk at this year’s virtual European Society for Blood and Marrow Transplantation (EBMT) meeting for patients and their families on hematopoeitic stem cell transplantation (HSCT) and graft-versus-host disease (GvHD). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Regis Peffault de Latour

RACE: evaluating eltrombopag in severe aplastic anemia
2:55
RACE: evaluating eltrombopag in severe aplastic anemia
Regis Peffault de Latour • 3 Sep 2020
Eltrombopag for aplastic anaemia in Europe
2:01
Eltrombopag for aplastic anaemia in Europe
Regis Peffault de Latour • 1 Sep 2020
Iptacopan for paroxysmal nocturnal hemoglobinuria
2:21
Iptacopan for paroxysmal nocturnal hemoglobinuria
Regis Peffault de Latour • 2 Sep 2020
Aplastic anemia: EHA highlights
1:01
Aplastic anemia: EHA highlights
Regis Peffault de Latour • 15 Jun 2019

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals